COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Robert Monreal Beltran Killed in Crash on 210 Freeway at Haven Avenue


Several Vehicles Involved in Fatal Rancho Cucamonga Accident

Rancho Cucamonga, CA (May 24, 2020) – A man was killed in a multi-vehicle crash in Rancho Cucamonga. The fatal accident occurred on the morning of May 24 on the 210 Freeway.

Several vehicles collided in the eastbound lane of the 210 Freeway at Haven Avenue. The cause of the crash is unknown. One of the drivers – Robert Monreal Beltran, 62, of Rancho Cucamonga – died at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of Robert Monreal Beltran.

#Rancho Cucamonga

#91737


May 11, 2020

Dairy Worker Killed During Robbery on South Ingomar Avenue

Hector DeLaCruz Arrested in Fatal Gustine Shooting...


June 9, 2020

Anthony Martinez Killed in Hit and Run Crash

Man Hit by Car in Fatal Laguna Hills Accident...


July 13, 2020

2 Injured in Crash on Highway 89 Near Pope Beach Drive

Motorcycle, Vehicle Collide in South Lake Tahoe Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.